GRTS - Gritstone bio GAAP EPS of -$0.31 beats by $0.05 revenue of $1.96M misses by $0.51M August, 09 2023 05:32 PM Gritstone Oncology Inc. 2023-08-09 17:32:16 ET Gritstone bio press release ( NASDAQ: GRTS ): Q2 GAAP EPS of -$0.31 beats by $0.05 . Revenue of $1.96M (-64.2% Y/Y) misses by $0.51M . For further details see: Gritstone bio GAAP EPS of -$0.31 beats by $0.05, revenue of $1.96M misses by $0.51M